NCT04274569

Brief Summary

This study evaluates and compares the effect of two types of calcium- and phosphate-containing fluoride varnishes to conventional fluoride varnishes in preventing early childhood caries.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
570

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 13, 2019

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

November 12, 2019

Completed
3 months until next milestone

First Posted

Study publicly available on registry

February 18, 2020

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 15, 2021

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2022

Completed
Last Updated

February 18, 2020

Status Verified

February 1, 2020

Enrollment Period

2.3 years

First QC Date

November 12, 2019

Last Update Submit

February 17, 2020

Conditions

Keywords

CariesFluoride vanishCalcium phosphateRandomised clinical trialRemineralisation

Outcome Measures

Primary Outcomes (1)

  • Proportion of children with new caries and new dmfs.

    24 months

Secondary Outcomes (1)

  • MS growth

    12 months and 24 months

Study Arms (3)

Sodium fluoride (NaF)

ACTIVE COMPARATOR

Group 1: Quarterly application of a 5% NaF varnish (Duraphat® Varnish, Colgate-Palmolive Ltd, (UK) Ltd., Guildford, Surrey, UK)

Other: NaF vanish

NaF plus tricalcium phosphate (TCP )

EXPERIMENTAL

Group 2: Quarterly application of 5% NaF-TCP (ClinproTM White Varnish; 3M ESPE, St Paul, MN, USA)

Other: NaF-TCP

NaF plus CPP-ACP

EXPERIMENTAL

Group 3: Quarterly application of a 5% NaF plus casein phosphopeptide-stabilized amorphous calcium phosphate complexes (CPP-ACP) (MI Varnish TM; GC corporation, Itabashi-Ku, Tokyo, Japan)

Other: NaF-CPP-ACP

Interventions

A disposable micro-brush will be used to apply the varnishes to all tooth surfaces. The fluoride varnish will be applied every 3 months, from baseline to 24-months follow-up.

Sodium fluoride (NaF)
NaF-TCPOTHER

A disposable micro-brush will be used to apply the varnishes to all tooth surfaces. The fluoride varnish will be applied every 3 months, from baseline to 24-months follow-up.

NaF plus tricalcium phosphate (TCP )

A disposable micro-brush will be used to apply the varnishes to all tooth surfaces. The fluoride varnish will be applied every 3 months, from baseline to 24-months follow-up.

NaF plus CPP-ACP

Eligibility Criteria

Age3 Years - 4 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Generally healthy children age between 3-4 of age with unremarkable medical history and at high caries risk with at least one carious lesion (precavitated or cavitated) (Agouropoulos et al 2014). The high caries risk children are chosen because it is anticipated that they will benefit more from the topical fluoride varnish application than the low caries risk children.

You may not qualify if:

  • Patients who had received professional fluoride application in the past 6 months
  • Patients with underlying medical history or special health care needs
  • Patient who are uncooperative or refuse the treatment
  • Patient who are allergic to milk protein (as MI VarnishTM contains "casein, a milk protein)
  • Patient with contraindication for fluoride varnish e.g. hypersensitivity to colophony and/or any other constituents
  • Patient who have primary teeth with enamel hypoplasia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Hong Kong

Hong Kong, 999077, Hong Kong

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor in Paediatric Dentistry

Study Record Dates

First Submitted

November 12, 2019

First Posted

February 18, 2020

Study Start

March 13, 2019

Primary Completion

July 15, 2021

Study Completion

October 1, 2022

Last Updated

February 18, 2020

Record last verified: 2020-02

Data Sharing

IPD Sharing
Will not share

Locations